3,182 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,374 increasing their positions, 1,338 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $222B → $196B (-$25.8B)

15% less first-time investments, than exits

New positions opened: 156 | Existing positions closed: 183

34% less funds holding in top 10

Funds holding in top 10: 249165 (-84)

Holders
3,182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
165
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18B
Puts
$3.23B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.25B
27
$1.17B
28
$1.13B
29
$1.12B
30
$1.08B
31
$1.03B
32
$925M
33
$921M
34
$917M
35
$898M
36
$869M
37
$862M
38
$757M
39
$728M
40
$673M
41
$660M
42
$638M
43
$637M
44
$613M
45
$611M
46
$595M
47
$586M
48
$580M
49
$554M
50
$519M